Hepatic Cell News Volume 6.11 | Mar 25 2022

    0
    16







    2022-03-25 | HCN 6.11


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.11 – 25 March, 2022
    TOP STORY

    Fibroblast Activation Protein Activated Antifibrotic Peptide Delivery Attenuates Fibrosis in Mouse Models of Liver Fibrosis

    Scientists reported a targeted antifibrotic peptide-delivery system in which fibroblast activation protein, which was overexpressed in fibrotic regions of the liver, liberated the antifibrotic peptide melittin by cleaving a fibroblast activation protein-specific site in the peptide.
    [Nature Communications]

    Full Article

    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    PUBLICATIONSRanked by the impact factor of the journal

    STAT5A Modulates CDYL2/SLC7A6 Pathway to Inhibit the Proliferation and Invasion of Hepatocellular Carcinoma by Targeting to mTORC1

    Investigators observed that chromodomain Y-like 2 (CDYL2) was down-regulated in human primary HCC tissues and the low levels of CDYL2 expression were correlated with poor survival.
    [Oncogene]

    Abstract

    The Proteomic Characterization of the Peritumor Microenvironment in Human Hepatocellular Carcinoma

    The proteomic characterization of the peritumor microenvironment of HCC revealed that the entire processes of HCC occurrence and progression differed substantially.
    [Oncogene]

    Full Article

    Targeted-Detection and Sequential-Treatment of Small Hepatocellular Carcinoma in the Complex Liver Environment by GPC-3-Targeted Nanoparticles

    The authors developed a tumor “cruise missile” designed to enhance the accuracy of small HCC visualization to 85.7% using combined ultrasound/photoacoustic imaging in complex liver environment, which facilitated sequential catalytic targeted therapy for small HCC.
    [Journal of Nanobiotechnology]

    Full ArticleGraphical Abstract

    CMTM6 Inhibits Tumor Growth and Reverses Chemoresistance by Preventing Ubiquitination of p21 in Hepatocellular Carcinoma

    Researchers found that the expression of CMTM6 was significantly reduced in HCC and predicted better prognosis of HCC patients. Through in vitro and in vivo experiments, CMTM6 was shown to inhibit the proliferation of HCC cells by blocking the G1/S phase transition.
    [Cell Death & Disease]

    Full Article

    Single Cell Transcriptional Diversity and Intercellular Crosstalk of Human Liver Cancer

    Investigators assessed transcriptional diversity in 15 liver cancer patients by single-cell transcriptome analysis and observed that transcriptional diversity of tumor cells was associated with stemness in liver cancer patients.
    [Cell Death & Disease]

    Full Article

    Matrix Stiffness-Induced Upregulation of Histone Acetyltransferase KAT6A Promotes Hepatocellular Carcinoma Progression through Regulating SOX2 Expression

    Scientists demonstrated that lysine acetyltransferase 6 A (KAT6A) expression was upregulated in HCC tissues and cell lines. Clinical analysis showed that increased KAT6A was significantly associated with malignant prognostic features and shorter survival.
    [British Journal of Cancer]

    Abstract

    The Monoacylglycerol Acyltransferase Pathway Contributes to Triacylglycerol Synthesis in HepG2 Cells

    The authors used selective small molecule inhibitors of monoacylglycerol acyltransferase 2 (MGAT2) and MGAT3 to determine the contributions of these enzymes to triacylglycerol production in liver cells.
    [Scientific Reports]

    Full Article

    Elevated Expression of RAB3B Plays Important Roles in Chemoresistance and Metastatic Potential of Hepatoma Cells

    RAB3B was identified as an up-regulated gene in both cancer stem-like sphere cells and prognostically poor hepatocellular carcinoma by RNA-sequencing.
    [BMC Cancer]

    Full Article

    Context Dependent Isoform Specific PI3K Inhibition Confers Drug Resistance in Hepatocellular Carcinoma Cells

    The bioactivities of inhibitors on PTEN adequate Huh7 and deficient Mahlavu cells were investigated with real time cell growth, cell cycle and cell migration assays.
    [BMC Cancer]

    Full Article

    Scientific resources to support your cancer research. Learn More!
    REVIEWS

    Neoadjuvant Approaches in Hepatocellular Carcinoma: There’s No Time Like the Present

    Investigators appraise the existing literature and current clinical trial landscape of neoadjuvant therapies in HCC.
    [Clinical Cancer Research]

    Abstract

    Hepatocellular Carcinoma: The Virus or the Liver?

    Scientists summarize the current literature on the impact of hepatitis D virus (HDV) in HCC development and discuss the potential interplay between hepatitis B, HDV and neighboring liver tissue in liver carcinogenesis.
    [Liver International]

    AbstractFull Article

    Noncoding RNA-Mediated Macrophage and Cancer Cell Crosstalk in Hepatocellular Carcinoma

    The authors provide an update on the regulation of noncoding RNAs in the crosstalk between macrophages and tumor cells in HCC.
    [Molecular Therapy-Oncolytics]

    AbstractFull ArticleGraphical Abstract

    INDUSTRY AND POLICY NEWS

    Oramed Completes Patient Enrollment in Phase II Oral Insulin NASH Trial

    Oramed Pharmaceuticals, Inc. announced it has completed enrollment of all patients in a Phase II trial of its oral insulin capsule ORMD-0801 for the treatment of non-alcoholic steatohepatitis (NASH).
    [Oramed Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    ISCT 2022 San Francisco Annual Meeting

    May 4 – 7
    San Francisco, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – Obesity Related Liver Cancer

    Baylor College of Medicine – Houston, Texas, United States

    Principal Scientific Researcher – Cell and Tissue Genomics

    Genentech, Inc. – South San Francisco, California, United States

    Senior Associate Scientist – Biology

    Gilead Sciences – Foster City, California, United States

    Postdoctoral Scientist – Liver Resident Memory T Cell

    Amsterdam UMC – Amsterdam, Netherlands

    Postdoctoral Fellow – Diabetes, Cardiovascular Disorders and Non-Alcoholic Steatohepatitis

    NIH National Heart, Lung, and Blood Institute – Bethesda, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter